Animal-derived natural products for hepatocellular carcinoma therapy: current evidence and future perspectives

• Váldodahkkit: Yichao Liao (Dahkki), Feng Wei (Dahkki), Zhelin He (Dahkki), Jingxue He (Dahkki), Yanlin Ai (Dahkki), Cui Guo (Dahkki), Li Zhou (Dahkki), Dan Luo (Dahkki), Chengen Li (Dahkki), Yueqiang Wen (Dahkki), Jinhao Zeng (Dahkki), Xiao Ma (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2024-05-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Hepatocellular carcinoma (HCC) has a high morbidity and mortality rate, and the survival rate of HCC patients remains low. Animal medicines have been used as potential therapeutic tools throughout the long history due to their different structures of biologically active substances with high affinity...